TrialInternational journal of clinical oncology2021

A phase II study of FOLFIRINOX with primary prophylactic pegfilgrastim for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer.

Mitsuhito Sasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.